Source: FierceBiotech Encore Dermatology, formed two years ago as a vehicle for three ex-Valeant products, has picked up a late-stage pipeline drug via a deal with India's Dr. Reddy's Laboratories. The Malvern, Pennsylvania, company says it has licensed a steroid candidate developed by Dr. Reddy's Promius Pharma subsidiary that has…...
Prollenium Medical Technologies Inc. announces U.S. FDA approval for its cross-linked hyaluronic acid dermal filler
Source: PR Newswire Prollenium Medical Technologies Inc., a leading medical device manufacturer, announced today its United States (U.S.) Food and Drug Administration (FDA) approval for its cross-linked hyaluronic acid dermal filler. Ario Khoshbin, Founder and CEO, stated "This is definitely one of our proudest moments as an organization. FDA approval…...
Has the Brent Saunders price-hike limit become a de facto pharma rule?
Source: Nearly one year ago, as the pharma industry was beset by pricing scrutiny, Allergan CEO Brent Saunders pledged to keep his company’s hikes under 10%. Since then, that pricing rule has spread—even among companies that haven't publicly promised to do the same. Bernstein analyst Ronny Gal reports that for…...